Strata Critical Medical, Inc.
For the period ended Nov 3, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 3, 2026 · Filed Nov 3, 2026
SRTA$5.56+5.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · SEQUENTIAL QUARTER COMPARISON
SEQUENTIAL QUARTER COMPARISON
| Three Months Ended September 30, · Three Months Ended June 30, | ||||
|---|---|---|---|---|
| 2026 · 2026 · % Change | ||||
| Revenue: | ||||
| Logistics | $44,899 | $48,240 | (6.9)% | |
| Transplant Clinical | 15,217 | 12,521 | 21.5% | |
| Other Clinical | 13,965 | 11,745 | 18.9% | |
| Total Clinical | 29,182 | 24,266 | 20.3% | |
| Total revenue | $74,081 | $72,506 | 2.2% | |
| Gross profit: | ||||
| Logistics (1) | $9,335 | $8,888 | 5.0% | |
| Clinical (2) | 7,485 | 6,327 | 18.3% | |
| Total gross profit | $16,820 | $15,215 | 10.5% | |
| Gross margin: | ||||
| Logistics | 20.8% | 18.4% | 240 | bps |
| Clinical | 25.6% | 26.1% | (50 | bps) |
| Total gross margin | 22.7% | 21.0% | 170 | bps |
| Adjusted SG&A | $8,926 | $9,115 | (2.1)% | |
(1) Net of depreciation expense of $1,329 and $1,417 for the three months ended September 30, 2026 and June 30, 2026, respectively.
(2) Net of depreciation expense of $382 and $370 for the three months ended September 30, 2026 and June 30, 2026, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.